doxil (Nanotherapeutics)
86
Structured Review
Nanotherapeutics
doxil
Doxil, supplied by Nanotherapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxil/doxil/10__1016_slash_j__nantod__2026__103040-32-14-6
Average 86 stars, based on 1 article reviews
Doxil, supplied by Nanotherapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/doxil/doxil/10__1016_slash_j__nantod__2026__103040-32-14-6
Average 86 stars, based on 1 article reviews
doxil - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Liposomes:Article Title: Nitric Oxide-Responsive Degradable Drug-Loaded Liposomal Nanomotors for the Treatment of Peritoneal Metastases Cancer. Article Snippet: As a drug delivery vehicle, liposomes still have problems such as lack of targeting, difficulty in achieving effective tumor tissue penetration, and cellular internalization.. Based on this, the drug-loaded liposome nanomotors with liposomes that can respond to NO degradation as carriers and loaded with anticancer drug DOX were designed for the treatment of peritoneal metastases cancer (arginine-functionalized-DSPE@NO-responsive-lipids-DOX, L-Arg@Lip-DOX).. The drug-loaded liposomal nanomotors have the ability to move toward tumors at high concentrations of ROS/iNOS, thereby achieving deep penetration and effective cellular internalization of tumor tissues. Membrane:Article Title: Nitric Oxide-Responsive Degradable Drug-Loaded Liposomal Nanomotors for the Treatment of Peritoneal Metastases Cancer. Article Snippet: As a drug delivery vehicle, liposomes still have problems such as lack of targeting, difficulty in achieving effective tumor tissue penetration, and cellular internalization.. Based on this, the drug-loaded liposome nanomotors with liposomes that can respond to NO degradation as carriers and loaded with anticancer drug DOX were designed for the treatment of peritoneal metastases cancer (arginine-functionalized-DSPE@NO-responsive-lipids-DOX, L-Arg@Lip-DOX).. The drug-loaded liposomal nanomotors have the ability to move toward tumors at high concentrations of ROS/iNOS, thereby achieving deep penetration and effective cellular internalization of tumor tissues. Article Title: Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model Article Snippet: .. Extracellular matrix proteins produced by CAFs in the tumor stroma impede the effective delivery of chemotherapeutic agents,11,12 resulting in poor responses in patients with pancreatic cancer.13 Due to recent advances in nanotechnology, the application of nanoparticles in cancer therapy has become a leading area in cancer research.12,14,15 Nanotherapeutics can achieve better therapeutic effects on tumors than free drugs based on the enhanced permeability and retention (EPR) effect of tumors.16 However, the benefits of anti-tumor nanotherapeutics such as Encapsulation:Article Title: Self-illuminating activatable chemotherapy enabled by pH-MPO-ROS cascade-amplified nanoparticles for cancer and metastatic lymph nodes Article Snippet: Lymph nodes (LNs) are the primary site of metastasis for various cancers spreading through the lymphatic system.. The role of lymph node dissection, as outlined by clinical guidelines, has increasingly been called into question.. Here, we developed a self-illuminating and pH-MPO-ROS cascade-activatable paclitaxel nanoparticle (PCAPN), which integrates ultra-pH-sensitive, self-illuminated imaging, in situ cascade gated activation of therapeutic agents to specifically eliminate the residual tumors and metastatic LNs after surgery. Produced:Article Title: Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model Article Snippet: .. Extracellular matrix proteins produced by CAFs in the tumor stroma impede the effective delivery of chemotherapeutic agents,11,12 resulting in poor responses in patients with pancreatic cancer.13 Due to recent advances in nanotechnology, the application of nanoparticles in cancer therapy has become a leading area in cancer research.12,14,15 Nanotherapeutics can achieve better therapeutic effects on tumors than free drugs based on the enhanced permeability and retention (EPR) effect of tumors.16 However, the benefits of anti-tumor nanotherapeutics such as Permeability:Article Title: Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model Article Snippet: .. Extracellular matrix proteins produced by CAFs in the tumor stroma impede the effective delivery of chemotherapeutic agents,11,12 resulting in poor responses in patients with pancreatic cancer.13 Due to recent advances in nanotechnology, the application of nanoparticles in cancer therapy has become a leading area in cancer research.12,14,15 Nanotherapeutics can achieve better therapeutic effects on tumors than free drugs based on the enhanced permeability and retention (EPR) effect of tumors.16 However, the benefits of anti-tumor nanotherapeutics such as Food & Beverages:Article Title: Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model Article Snippet: .. Extracellular matrix proteins produced by CAFs in the tumor stroma impede the effective delivery of chemotherapeutic agents,11,12 resulting in poor responses in patients with pancreatic cancer.13 Due to recent advances in nanotechnology, the application of nanoparticles in cancer therapy has become a leading area in cancer research.12,14,15 Nanotherapeutics can achieve better therapeutic effects on tumors than free drugs based on the enhanced permeability and retention (EPR) effect of tumors.16 However, the benefits of anti-tumor nanotherapeutics such as Modification:Article Title: Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model Article Snippet: .. Extracellular matrix proteins produced by CAFs in the tumor stroma impede the effective delivery of chemotherapeutic agents,11,12 resulting in poor responses in patients with pancreatic cancer.13 Due to recent advances in nanotechnology, the application of nanoparticles in cancer therapy has become a leading area in cancer research.12,14,15 Nanotherapeutics can achieve better therapeutic effects on tumors than free drugs based on the enhanced permeability and retention (EPR) effect of tumors.16 However, the benefits of anti-tumor nanotherapeutics such as Clinical Proteomics:Article Title: Development of Dual Diagnostic-Therapeutic Nanoformulation Effective Against Pancreatic Cancer in Animal Model Article Snippet: .. Extracellular matrix proteins produced by CAFs in the tumor stroma impede the effective delivery of chemotherapeutic agents,11,12 resulting in poor responses in patients with pancreatic cancer.13 Due to recent advances in nanotechnology, the application of nanoparticles in cancer therapy has become a leading area in cancer research.12,14,15 Nanotherapeutics can achieve better therapeutic effects on tumors than free drugs based on the enhanced permeability and retention (EPR) effect of tumors.16 However, the benefits of anti-tumor nanotherapeutics such as other:Article Title: Long-acting lipid-based nanomedicines: rethinking from structure-based rational design to in vivo fate evaluation. Article Snippet: Long-acting lipid-based nanomedicines (LaLBNs) aim to sustain therapeutic effect through prolonged exposure and controlled drug release.. However, extended circulation does not always translate into improved clinical outcomes.. For instance, polyethylene glycol (PEG)-modified liposomes show enhanced pharmacokinetic (PK) parameters such as half-life and area under the curve, yet their benefits, as observed with Doxil®, often fail to meaningfully surpass free doxorubicin. |